Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture capital investing in health technology.
Our Investment Universe
We look for audacious companies commercializing globally relevant medical devices, diagnostics, therapeutics and digital health innovations that are prioritizing huge market opportunities in women, children and adolescent health.
We value real world and clinical data.
We focus on 4 key sectors:
- Sexual and reproductive health,
- Maternal, newborn and child health,
- General health, including chronic diseases, and
- Health software infrastructure.
We invest in companies addressing gender health inequalities.
Positive impact and financial returns are not mutually exclusive. We seek opportunities that offer both high impact & high returns.
We believe good health is a right that should not be restricted by gender, age, race, wealth and borders.
We hold ourselves to the highest standard of impact investing and implement recognized impact management processes. We invest with a gender and diversity lens.
Health technologies are more scalable than ever before. The time is now to take a global tailored approach in this sector.
We are enablers
We are specialists in women, children and adolescent health with deep expertise in health technology. We are hands-on investors and support our exceptional management teams with access to new markets, unique forms of capital and health technology expertIse in North America, Europe as well as global markets.
We unlock global impact opportunities
Cutting edge technologies take decades to reach underserved communities. We work with management teams to fast track the process.
Emerging Impact Manager Award
– 2022 –
We work with visionary teams to leapfrog access to world leading affordable technologies for women, children and adolescents.
Toronto venture firm backing women and children’s health technologies taps J&J, Gates-backed group in quest to raise US$100-million fund
A Toronto venture capital firm aiming to invest in technologies that address health needs of women and children globally has secured nearly a third of its US$100-million fundraising goal.
PHD, CFA, ICD.D
Annie Thériault, Managing Partner at CBIV, has been immersed in impact investing, venture capital, royalty financing, and capital markets throughout her career. As a venture capital investor and venture advisor, she worked with high impact companies to mobilize more than $100 million in non-dilutive capital. Annie was previously a director on the boards of several North American venture-backed companies, is an advisor to crowdfunding fintech company FrontFundr, and, prior to the launch of CBIV, was Chief Investment Officer at Grand Challenges Canada. Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder, and holds the ICD.D designation. She also has a master’s degree in Business Economics from Wilfrid Laurier University and a Bachelor of Science with First Class Honours in Chemistry from Mount Allison University.
Donna Parr, Managing Partner at CBIV, has more than 30 years of experience managing venture capital, growth equity, and private debt investment portfolios of up to $1 billion. She has managed two biotech related funds (GrowthWorks Canadian Fund and Canadian Medical Discoveries Fund) and has held roles at several notable pension funds and firms, including OMERS, CPP, and TD Capital. She is currently on the boards of Constellation Software and Topicus.com. Donna holds a master’s degree in International Relations from the University of Toronto and earned her MBA from Schulich School of Business. She holds the ICD.D designation.
Cyriac Alappat, Principal at CBIV, brings to the team expertise in global health, international partnership networks, early-stage growth and financing as well as organizational behavior. Cyriac was part of the founding team of CBIV. Prior to the launch of the firm, he was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Cyriac often brings the view of the founder to the table, having joined Grand Challenges Canada, after a number of years operating a FinTech company he co-founded to accelerate the angel investment process and scaling in the MENA region. Cyriac started his career at an executive recruiting firm after obtaining his Chartered Accountant (CPA, CA) designation as part of the audit practice of E&Y. Cyriac earned a Bachelor’s Degree in Business Administration from Wilfrid Laurier University.
Megan Dover, Principal at CBIV, has more than 14 years of experience in impact investing, venture advisory, M&A, business strategy, Financial Planning & Analysis and angel investing. Megan was part of the founding team of CBIV. Prior to the launch of the firm, she was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Megan brought expertise in a number of areas to the role, having previously held roles in finance and strategy for a public resource company, worked in management consulting for a global consulting firm, been part of an R&D team for a biotech startup and as an advisor and angel investor at the Creative Destruction Lab (CDL). Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.
Cross-Border Impact Ventures
661 University Avenue, MaRs Centre, West Tower, Suite 1720, Toronto, ON M5G 1M1